Superior Group of Companies Reports Q2 2026 Financial Results with Increased Sales but Decreased Net Income

Superior Group of Companies, Inc. reported its financial results for the second quarter of 2026, revealing a modest increase in net sales and a notable rise in net income compared to the same period last year. The company generated net sales of $147.8 million for the three months ended June 30, 2026, a 2.6% increase from $144.0 million in the prior year. For the first half of 2026, net sales reached $288.7 million, up 2.7% from $281.1 million in the same period of 2025. The increase in sales was primarily driven by a 6.2% rise in the Branded Products segment, which reported $98.4 million in sales, while the Healthcare Apparel segment saw a slight decline of 3.6% to $27.2 million.

Despite the increase in sales, the company faced challenges that impacted profitability. Net income for the second quarter of 2026 was $1.2 million, down from $1.6 million in the same quarter of 2025, reflecting a 21.3% decrease. This decline was attributed to a $2.6 million trade name impairment charge in the Healthcare Apparel segment and inventory write-downs, which overshadowed the growth in the Branded Products and Contact Centers segments. Adjusted EBITDA, a non-GAAP measure, increased by 26.6% to $7.7 million, indicating improved operational performance despite the net income drop.

Operationally, the company reported a decrease in selling and administrative expenses, which fell to $51.3 million from $52.2 million year-over-year. This reduction was primarily due to expense leverage in the Branded Products segment and lower costs in the Contact Centers segment. The gross margin for the company was 38.0%, slightly down from 38.4% in the previous year, with the Branded Products segment showing an improvement in gross margin rate to 36.5%, while the Healthcare Apparel segment's margin decreased to 32.9% due to the impairment charge.

Looking ahead, Superior Group of Companies is focused on strategic growth across its segments, particularly in Branded Products and Healthcare Apparel. The company continues to navigate challenges related to market conditions, including tariff impacts and supply chain disruptions. Management remains optimistic about future performance, citing opportunities for cross-selling and expanding market share, particularly in the healthcare sector. The company also plans to maintain its dividend payments and has initiated a share repurchase program to enhance shareholder value.